RDHL

Redhill Boipharma News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Redhill Boipharma Ltd RDHL NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.29 -4.38% 6.33 20:00:00
Open Price Low Price High Price Close Price Prev Close
6.61 6.30 6.61 6.33 6.62
more quote information »

Recent News

Date Time Source Heading
7/27/20218:06IHNWFeaturedKomo Plant Based Foods Adds Dean's Dairy & Specialty Foods for Distribution
7/27/20219:30IHNWFeaturedEmerging Markets Report: On the Bright Side
7/27/20219:59IHNWFeaturedThe new ad-free antidote to fake news, privacy breach and unfair competition?
7/26/202109:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/22/202110:11IHNWRedHill Biopharma Announces Settlement of Movantik®..
7/22/202109:26EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/22/202109:20RNSNONRedHill Biopharma Ltd RedHill Settles Movantik(R) Apotex..
7/22/202109:19PRNUSRedHill Biopharma Announces Settlement of Movantik® Patent..
7/20/202107:03IHNWRedHill Biopharma Significantly Extends Unrestricted..
7/20/202107:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/20/202107:00PRNUSRedHill Biopharma Significantly Extends Unrestricted..
7/19/202107:50SEEKRedHill Bio reports last patient out for Phase 2/3 COVID-19..
7/19/202107:10IHNWRedHill Biopharma Announces Last Patient Out for Phase 2/3..
7/19/202107:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/19/202107:00PRNUSRedHill Biopharma Announces Last Patient Out for Phase 2/3..
7/13/202111:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/13/202111:01IHNWRedHill Biopharma's Movantik® Added as Unrestricted..
7/13/202111:00PRNUSRedHill Biopharma's Movantik® Added as Unrestricted..
6/28/202107:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/28/202107:00PRNUSRedHill Biopharma's Opaganib Inhibits COVID-19 Variants in..
6/21/202108:50SEEKRedHill Biopharma highlights presentation of oral opaganib..
6/21/202107:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/21/202107:00PRNCARedHill Biopharma Announces Presentation of Positive Oral..
6/10/202108:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/09/202107:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/09/202107:00PRNUSRedHill Biopharma to Present at the BIO Digital..
6/07/202107:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/07/202107:00PRNUSRedHill Biopharma Completes Enrollment of Oral Opaganib..
5/27/202111:09SEEKRedHill Biopharma Q1 loss narrows amid uptick in..
5/27/202107:03SEEKRedHill EPS beats by $0.29, misses on revenue
5/27/202107:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/27/202107:00PRNUSRedHill Biopharma Reports First Quarter 2021 Financial..
5/26/202116:01EDGARAmended Tender Offer Statement by Issuer (sc To-i/a)
5/26/202111:06TRMN3 “Strong Buy” Stocks Under $10 With Triple-Digit Upside
5/26/202108:16SEEKRedHill gets U.S. patent application allowances for opaganib..
5/26/202107:00EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/26/202107:00PRNUSRedHill Biopharma Receives Allowances for U.S. Patent..
5/24/202107:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/24/202107:00PRNUSRedHill Biopharma Presents Analyses of Movantik Onset of..
5/21/202112:28EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/21/202112:15PRNUSRedHill Biopharma Presents a New Travelers' Diarrhea..
5/20/202107:00PRNUSRedHill Biopharma to Host First Quarter 2021 Financial..
5/18/202115:20SEEKRedHill Biopharma is a new buy at H.C. Wainwright;..
5/03/202109:07EDGARSecurities Registration: Employee Benefit Plan (s-8)
4/26/202106:31EDGARTender Offer Statement by Issuer (sc To-i)
4/09/202107:42SEEKDSMB gives green light for RedHill Bio's late-stage opaganib..
4/09/202107:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/09/202107:00PRNUSRedHill Biopharma's Phase 2/3 COVID-19 Study of Opaganib..
4/09/202106:04EDGARNotice of Effectiveness (effect)
4/08/202116:38EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
3/30/202108:01EDGARSecurities Registration (foreign Private Issuer) (f-3)
3/25/202109:36SEEKRedHill enters Movantik patent litigation settlement with..
3/25/202109:31EDGARSecurities Registration: Employee Benefit Plan (s-8)
See more news about this stock »


Your Recent History
NASDAQ
RDHL
Redhill Bo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.